RNA - Atrium Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$25.00
DETAILS
HIGH:
$25.00
LOW:
$25.00
MEDIAN:
$25.00
CONSENSUS:
$25.00
UPSIDE:
90.99%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 100.0% |
| EBIT Margin | -412.6% |
| EBITDA Margin | -410.8% |
| Operating Margin | -412.6% |
| Pretax Margin | -412.6% |
| Cont. Ops Margin | -411.9% |
| Net Margin | -411.9% |
| Bottom Line Margin | -411.9% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 6.53 |
| Quick Ratio | 6.53 |
| Solvency Ratio | -1.075 |
| Cash Ratio | 6.46 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-3.29
Peers avg: 39.6
|
| PEG Ratio | 0.00 |
| Forward PEG | 0.00 |
| Price/Book | 1.22 |
| Price/Sales | 13.56 |
| Price/FCF | -5.93 |
| Price/Op Cash Flow | -6.14 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0132 |
| Debt/Equity | 0.0177 |
| Debt/Capital | 0.0174 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.34 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.00 |
| Operating Cash Flow Ratio | -0.984 |
| Operating Cash Flow/Sales | -220.9% |
| Free Cash Flow/Operating Cash Flow | 103.5% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | 0.00 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -11.20 |
| Capital Expenditure Coverage | -28.46 |
| Dividend + Capital Expenditure Coverage | -28.46 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 1.09 |
| EPS | -4.481 |
| Debt/Share | 0.2146 |
| Cash/Share | 15.78 |
| Book Value/Share | 12.11 |
| Tangible BV/Share | 12.11 |
| Equity/Share | 12.11 |
| Operating Cash Flow/Share | -2.403 |
| Capital Expenditure/Share | 0.084 |
| FCF/Share | -2.488 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 0.998 |
| Earnings Before Tax/EBIT | 1.000 |
| Price/Fair Value | 1.22 |
| Debt/Market Cap | 0.0000 |
| Effective Tax Rate | 0.2% |
| Enterprise Value Multiple | 0.18 |